Calcipotriol delivery into the skin with PEGylated liposomes

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 81, Issue 3, 2012, Pages 532-539

  Knudsen, Nina Østergaard ^a,b   Rønholt, Stine ^a,b,c   Salte, Ragnhild Djønne ^a,b   Jorgensen, Lene ^a   Thormann, Thorsten ^b   Basse, Line Hollesen ^b   Hansen, Jens ^b   Frokjaer, Sven ^a   Foged, Camilla ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LEO PHARMA A S   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Calcipotriol; Drug delivery; Liposome; Nanomedicine; PEGylation; Topical delivery

Indexed keywords

CALCIPOTRIOL; DISTEAROYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHOETHANOLAMINE; LIPOSOME; MACROGOL; PHOSPHOETHANOLAMINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; COLLOID; CONTROLLED STUDY; DRUG RELEASE; DRUG STABILITY; NONHUMAN; PHASE TRANSITION; PHYSICAL CHEMISTRY; SKIN; SKIN PENETRATION; STRATUM CORNEUM; SWINE;

ADMINISTRATION, CUTANEOUS; ANIMALS; CALCITRIOL; DERMATOLOGIC AGENTS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; LIPOSOMES; PARTICLE SIZE; PERMEABILITY; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; SKIN; SKIN ABSORPTION; SWINE;

EID: 84863774441     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.04.005     Document Type: Article

References (50)

1. J.A. Bouwstra, P. Honeywell-Nguyen, G. Gooris, M. Ponec, Structure of the skin barrier and its modulation by vesicular formulations, Progr. Lipid Res. 42 (2003) 1-36. (Pubitemid 35418207)
2. K. Moser, K. Kriwet, A. Naik, Y. Kalia, R. Guy, Passive skin penetration enhancement and its quantification in vitro, Eur. J. Pharm. Biopharm. 52 (2001) 103-112. (Pubitemid 32755887)
3. M. Brown, Dermal and transdermal drug delivery systems: current and future prospects, Drug Deliv. 13 (2006) 175-187.
4. H.A. Benson, Elastic liposomes for topical and transdermal drug delivery, Methods Mol. Biol. 605 (2010) 77-86.
5. N.O. Knudsen, L. Jorgensen, J. Hansen, C. Vermehren, S. Frokjaer, C. Foged, Targeting of liposome-associated calcipotriol to the skin: effect of liposomal membrane fluidity and skin barrier integrity, Int. J. Pharm. 416 (2011) 478-485.
6. D.D. Verma, S. Verma, G. Blume, A. Fahr, Particle size of liposomes influences dermal delivery of substances into skin, Int. J. Pharm. 258 (2003) 141-151. (Pubitemid 36712878)
7. B. Biruss, C. Valenta, Comparative characterization of the physicochemical behavior and skin permeation of extruded DPPC liposomes modified by selected additives, J. Pharm. Sci. 96 (2007) 2171-2176. (Pubitemid 47280109)
8. C. Sinico, M. Manconi, M. Peppi, F. Lai, D. Valenti, A. Fadda, Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction, J. Control. Release 103 (2005) 123-136. (Pubitemid 40248567)
9. G. Cevc, Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery, Crit. Rev. Ther. Drug Carrier Syst. 13 (1996) 257-388. (Pubitemid 27024259)
10. H.Y. Thong, H. Zhai, H.I. Maibach, Percutaneous penetration enhancers: an overview, Skin Pharmacol. Physiol. 20 (2007) 272-282. (Pubitemid 350014982)
11. G. Cevc, G. Blume, Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage, Biochim. Biophys. Acta 1663 (2004) 61-73. (Pubitemid 38625580)
12. S.K. Jain, Y. Gupta, A. Jain, K. Rai, Enhanced transdermal delivery of acyclovir sodium via elastic liposomes, Drug Deliv. 15 (2008) 141-147. (Pubitemid 351465715)
13. M. Trotta, E. Peira, M.E. Carlotti, M. Gallarate, Deformable liposomes for dermal administration of methotrexate, Int. J. Pharm. 270 (2004) 119-125. (Pubitemid 38077093)
14. P.L. Honeywell-Nguyen, A.M. de Graaff, H.W. Groenink, J.A. Bouwstra, The in vivo and in vitro interactions of elastic and rigid vesicles with human skin, Biochim. Biophys. Acta 1573 (2002) 130-140. (Pubitemid 35217934)
15. G. Cevc, A. Schätzlein, H. Richardsen, Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements, Biochim. Biophys. Acta 1564 (2002) 21-30. (Pubitemid 34717865)
16. G.M. El Maghraby, A.C. Williams, Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin, Exp. Opin. Drug Deliv. 6 (2009) 149-163.
17. D. Needham, T. McIntosch, D. Lasic, Repulsive interactions and mechanical stability of polymer-grafted lipid membranes, Biochim. Biophys. Acta 1108 (1992) 40-48.
18. C. Allen, S.N. Dos, R. Gallagher, G.N. Chiu, Y. Shu, W.M. Li, S.A. Johnstone, A.S. Janoff, L.D. Mayer, M.S. Webb, M.B. Bally, Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol), Biosci. Rep. 22 (2002) 225-250. (Pubitemid 35222733)
19. M.L. Immordino, F. Dosio, L. Cattel, Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential, Int. J. Nanomed. 1 (2006) 297-315.
20. D.D. Lasic, Novel applications of liposomes, Trends Biotechnol. 16 (1998) 307-321. (Pubitemid 28305254)
21. M. Woodle, Surface-modified liposomes: assessment and characterization for increased stability and prolonged blood circulation, Chem. Phys. Lipids 64 (1993) 249-262. (Pubitemid 23290877)
22. M. Silvander, M. Johnsson, K. Edwards, Effects of PEG-lipids on permeability of phosphatidylcholine/cholesterol liposomes in buffer and in human serum, Chem. Phys. Lipids 97 (1998) 15-26. (Pubitemid 28557010)
23. S. Piperoudi, D. Fatouros, P.V. Ioannou, P. Frederik, S.G. Antimisiaris, Incorporation of PEG-lipids in arsonoliposomes results in formation of highly stable arsenic-containing vesicles, Chem. Phys. Lipids 139 (2006) 96-106. (Pubitemid 43183734)
24. T. Schneider, A. Sachse, J. Leike, G.S.M. Rössling, M. Drechsler, M. Brandl, Surface modification of continuously extruded contrast-carring liposomes: effect on their physical properties, Int. J. Pharm. 132 (1996) 9-20.
25. W.L. Hinrichs, F.A. Mancenido, N.N. Sanders, K. Braeckmans, S.C. De Smedt, J. Demeester, H.W. Frijlink, The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying, Int. J. Pharm. 311 (2006) 237-244.
26. S. Jain, A. Tiwary, N. Jain, PEGylated elastic liposomal formulation for lymphatic targeting of zidovudine, Curr. Drug Deliv. 5 (2008) 275-281.
27. M. DeLuca, C.M. Ward, K. Ohmori, R.K. Andrews, M.C. Berndt, Jararhagin and Jaracetin - Novel snake venom inhibitors of the integrin collagen receptor, alpha(2)beta(1), Biochem. Biophys. Res. Commun. 206 (1995) 570-576.
28. J. Ivaska, J. Kapyla, O. Pentikainen, A.R. Hoffren, J. Hermonen, P. Huttunen, M.S. Johnson, J. Heino, A peptide inhibiting the collagen binding function of integrin alpha I-2 domain, J. Biol. Chem. 274 (1999) 3513-3521. (Pubitemid 29077192)
29. N.O. Knudsen, R.M. Schiffelers, L. Jorgensen, J. Hansen, S. Frokjaer, C. Foged, Design of cyclic RKKH peptide-conjugated PEG liposomes targeting the integrin alpha(2)beta(1) receptor, Int. J. Pharm. (2012).
30. W.C. Parks, What is the alpha(2)beta(1) integrin doing in the epidermis?, J Invest. Dermatol. 127 (2007) 264-266. (Pubitemid 46106900)
31. R. Saraceno, T. Gramiccia, P. Frascione, S. Chimenti, Calcipotriene/betamethasone in the treatment of psoriasis: a review article, Expert Opin. Pharmacother. 10 (2009) 2357-2365.
32. Y. Bury, D. Ruf, C.M. Hansen, A.M. Kissmeyer, L. Binderup, C. Carlberg, Molecular evaluation of vitamin D3 receptor agonists designed for topical treatment of skin diseases, J. Invest. Dermatol. 116 (2001) 785-792. (Pubitemid 32467661)
33. J.J.N. Cirunay, Y. Vander Heyden, J. Plaizier-Vercammen, Separation from related compounds and assay of calcipotriol by high-performance liquid chromatography, J. Chromatogr. Sci. 36 (1998) 417-421. (Pubitemid 128479002)
34. J.C.M. Stewart, Colorimetric determination of phospholipids with ammonium ferrothiocyanate, Anal. Biochem. 104 (1980) 10-14. (Pubitemid 10045896)
35. A. Pinazo, X.Y. Wen, Y.C. Liao, A.J. Prosser, E.I. Franses, Comparison of DLPC and DPPC in controlling the dynamic adsorption and surface tension of their aqueous dispersions, Langmuir 18 (2002) 8888-8896. (Pubitemid 35361317)
36. D.C. Montgomery, Design and Analysis of Experiments, 7th ed., Wiley, Hoboken, 2010.
37. W. Kenworthy, S. Simon, T. McIntosch, Structure and phase behavior of lipid suspensions containing phospholipids with covalently attached poly(ethylene glycol), Biophys. J. 68 (1995) 1903-1920.
38. I. Dick, R. Scott, Pig ear skin as an in vitro model for human skin permeability, J. Pharm. Pharmacol. 44 (1992) 640-645.
39. U. Jacobi, M. Kaiser, R. Toll, S. Mangelsdorf, H. Audring, N. Otberg, W. Sterry, J. Lademann, Porcine ear skin: an in vitro model for human skin, Skin Res. Technol. 13 (2007) 19-24. (Pubitemid 46152448)
40. M.M. Domingues, P.S. Santiago, M.A.R.B. Castanho, N.C. Santos, What can light scattering spectroscopy do for membrane-active peptide studies, J. Pep. Sci. 14 (2008) 394-400. (Pubitemid 351540897)
41. A. Kenworthy, K. Hristova, D. Needham, T. McIntosh, Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol), Biophys. J. 68 (1995) 1921-1936.
42. S. Mabrey, J.M. Sturtevant, Investigation of phase transitions of lipids and lipid mixtures by sensitivity differential scanning calorimetry, Proc. Natl. Acad. Sci. USA 73 (1976) 3862-3866.
43. G.M. El Maghraby, A.C. Williams, B.W. Barry, Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes, Int. J. Pharm. 276 (2004) 143-161. (Pubitemid 38542995)
44. A. Hasanovic, C. Hollick, K. Fischinger, C. Valenta, Improvement in physicochemical parameters of DPPC liposomes and increase in skin permeation of aciclovir and minoxidil by the addition of cationic polymers, Eur. J. Pharm. Biopharm. 75 (2010) 148-153.
45. N. Dragicevic-Curic, S. Grafe, B. Gitter, S. Winter, A. Fahr, Surface charged temoporfin-loaded flexible vesicles: in vitro skin penetration studies and stability, Int. J. Pharm. 384 (2010) 100-108.
46. Y. Er, T.J. Barnes, D. Fornasiero, C.A. Prestidge, The encapsulation and release of guanosine from PEGylated liposomes, J. Liposome Res. 19 (2009) 29-36.
47. L. Simonsen, G. Hoy, E. Didriksen, J. Persson, N. Melchior, J. Hansen, Development of a new formulation combining calcipotriol and betamethasone dipropionate in an ointment vehicle, Drug Dev. Ind. Pharm. 30 (2004) 1095-1102. (Pubitemid 39578002)
48. Y.K. Lin, Z.R. Huang, R.Z. Zhuo, J.Y. Fang, Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery, Int. J. Nanomed. 5 (2010) 117-128.
49. K. Yamaguchi, T. Mitsui, Y. Aso, K. Sugibayashi, Structure-permeability relationship analysis of the permeation barrier properties of the stratum corneum and viable epidermis/dermis of rat skin, J. Pharm. Sci. 97 (2008) 4391-4403.
50. S. Ben-Shabat, R. Benisty, U. Wormser, A.C. Sintov, Vitamin D3-based conjugates for topical treatment of psoriasis: synthesis, antiproliferative activity, and cutaneous penetration studies, Pharm. Res. 22 (2005) 50-57. (Pubitemid 40558145)